Atrial septal defect occluders


 * Associate Editors-In-Chief: Priyamvada Singh, MBBS mailto:psingh@perfuse.org; ; Assistant Editor-In-Chief: Kristin Feeney, B.S. mailto:kfeeney@perfuse.org

Overview
Percutaneous transcatheter closure is used in limited atrial septal defect cases. The Food and Drug Administration has only authorized the use of percutaneous closure in ostium secundum patients.

The Food and Drug Administration authorized Occluders
The Food and Drug Administration has authorized the following percutaenous transcatheters for usage:
 * Amplatzer septal occluder
 * CardioSEAL
 * HELEX septal occluder
 * Sideris patch